1.	Phase II Study of Desferrioxamine for Children with Refractory Lymphoblastic Leukemia and non-Hodgkin's Lymphoma (Summary Last Modified 08/98) Phase: Phase II Type: Treatment Status: Completed Age: 21 and under at diagnosis Sponsor: NCI Protocol IDs: POG-9461
2.	Phase II Randomized Study of Topotecan with vs without Cyclophosphamide and with vs without an Investigational Window Study of Deferoxamine for Refractory Neuroblastoma (Summary Last Modified 10/1999) Phase: Phase II Type: Treatment Status: Closed Age: 21 or under at diagnosis Sponsor: NCI Protocol IDs: POG-P9462, CCG-P9462, POG-9462
3.	Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload Phase: Phase II Type: Supportive care Status: Closed Age: 10 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CICL670A2206, 2007-000766-20, NCT00600938
4.	Phase I Trial of Desferrioxamine in Children with Recurrent or Refractory Neuroblastoma (Summary Last Modified 09/93) Phase: Phase I Type: Treatment Status: Closed Age: 21 and under Sponsor: NCI Protocol IDs: POG-9248